Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EPOGEN for Nephrogenic anaemia: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 15 adverse event reports in the FDA FAERS database where EPOGEN was used for Nephrogenic anaemia.

Most Reported Side Effects for EPOGEN

Side Effect Reports % Deaths Hosp.
Incorrect product storage 35 23.0% 0 0
Haemoglobin decreased 20 13.2% 0 3
Drug ineffective 11 7.2% 0 0
Medication error 11 7.2% 0 0
Aplasia pure red cell 9 5.9% 0 3
Haemoglobin abnormal 9 5.9% 0 0
Anaemia 8 5.3% 0 3
Therapeutic response decreased 7 4.6% 0 0
Drug hypersensitivity 6 4.0% 0 0
Pruritus 6 4.0% 0 0
Death 5 3.3% 5 0

Other Indications for EPOGEN

Product used for unknown indication (63) Renal failure chronic (54) Anaemia (11)

Other Drugs Used for Nephrogenic anaemia

DARBEPOETIN ALFA (5,332) METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA (2,331) ARANESP (1,740) DAPRODUSTAT (859) ERYTHROPOIETIN (750) PEGZEREPOETIN ALFA (325) EPOETIN ALFA-EPBX (169) VADADUSTAT (140) MIRCERA (100) ENARODUSTAT (66)

Related Pages

EPOGEN Full Profile All Nephrogenic anaemia Drugs EPOGEN Demographics EPOGEN Timeline